Table 1 CARMA patient cardiovascular clinical characteristics
From: Early cardio-oncology intervention in thoracic radiotherapy: prospective single-arm pilot study
Characteristic | n (%) or median (IQR) |
|---|---|
Age | 71 (63–77) |
Sex (as biological attribute) | |
Female | 13 (65%) |
Male | 7 (25%) |
Ethnicity | |
Hispanic/Latin(x) | 16 (80%) |
Non-Hispanic/Latin(x) | 4 (20%) |
Race | |
Asian | 2 (10%) |
Black or African American | 1 (5%) |
White | 17 (85%) |
Cardiovascular risk factors | |
Hypertension | 9 (45%) |
Hyperlipidemia | 10 (50%) |
Diabetes mellitus | 1 (5%) |
Chronic kidney disease | 3 (15%) |
Chronic obstructive pulmonary disease | 2 (10%) |
Smoking | |
Never | 10 (50%) |
Current | 1 (5%) |
Former | 9 (45%) |
Pack-years | 30 (15-39) |
Valvular heart disease | 2 (10%) |
Arrhythmia | 2 (10%) |
Atherosclerotic cardiovascular disease | 7 (35%) |
Coronary artery disease | 5 (25%) |
Myocardial infarction | 3 (15%) |
Ischemic heart failure | 1 (5%) |
Ischemic stroke | 1 (5%) |
Cardiovascular data, labs | |
Systolic blood pressure | 128 (116-138) |
Diastolic blood pressure | 71 (63-83) |
Total cholesterol (mg/dL) | 159 (143-109) |
LDL-C (mg/dL) | 86 (59-102) |
HgbA1c (%) | 5.4 (5.3–5.8) |
Cardiovascular Medications | |
Statin | 13 (65%) |
Anti-platelet | 5 (25%) |
Oral anti-hyperglycemic | 2 (10%) |
Anti-hypertensive | 10 (50%) |
